Login to Your Account



Norway Biotechs Seek €300M Bailout to Ease Funding Crisis

By Cormac Sheridan


Wednesday, December 24, 2008

No Abstract

 

BioWorld International Correspondent

The Oslo Cancer Cluster, a Norwegian industry and research cluster focused on oncology, is seeking a €300 million (US$418 million) government bailout to help the country's fledgling biotechnology sector to weather the international financial crisis.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription